Home› Tender for 7.1) Generic Description: supply Of Active Ingredient Medications: Interferon Beta 1-a, Cannabinol-ronabinol And Avelumab, Dispensed At The University Hospital Dependent On Ingesa For Patients Of The Melilla Health Care Management. 7.2) lot 1: Interferon, Spain

Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria. has issued a public tender related to 7.1) Generic Description: supply Of Active Ingredient Medications: Interferon Beta 1-a, Cannabinol-ronabinol And Avelumab, Dispensed At The University Hospital Dependent On Ingesa For Patients Of The Melilla Health Care Management. 7.2) lot 1: Interferon in Spain. Interested bidders can submit applications before 01 Jul 2026.

Tender Notice

Tender Notice
Tender TI Ref No
533970515
Tender Date
12 Jun 2026
Tender Description
Tender for 7.1) Generic Description: supply Of Active Ingredient Medications: Interferon Beta 1-a, Cannabinol-ronabinol And Avelumab, Dispensed At The University Hospital Dependent On Ingesa For Patients Of The Melilla Health Care Management. 7.2) lot 1: Interferon
Tender Deadline
⏰ 01 Jul 2026 Closing soon
Tender Project Location
Spain
Tender Sector
Healthcare & Medical - Medical Tenders
Tender CPV
Human Medicine Tenders
Tender Estimated Cost
EUR 690935
Tender Document Type
Tender Notice
Tender Organization Name
🔒 Members only Click for more details
Unlock Full Details — Register Free
Start with receiving Free Data Samples related to your Products and Services
✓
Live Tender Updates from worldwide
✓
Access to original Tender Documents
✓
Information on Upcoming Projects & Contract Awards
✓
Bid Assistance Services
✓
Competitor Analysis & Industry Trends
✓
Daily Custom Email Alerts by Sector & Country

Similar Tenders

View All Healthcare & Medical - Medical Tenders Tenders ->

Register to View Tenders

Start Your Business Journey. Register now for 3 days Free Sample Tenders & AI Website Demo.

Already have an account? Login here

By registering you agree to our Terms & Conditions and Privacy Policy.